Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple-ascending doses of ACT-1014-6470, an oral complement factor 5a receptor 1 (C5a1 receptor) antagonist: Tolerability, pharmacokinetics and target engagement.
Anliker-Ort M, Dingemanse J, Farine H, Groenen P, Kornberger R, van den Anker J, Kaufmann P. Anliker-Ort M, et al. Among authors: groenen p. Br J Clin Pharmacol. 2023 Jan;89(1):380-389. doi: 10.1111/bcp.15508. Epub 2022 Sep 7. Br J Clin Pharmacol. 2023. PMID: 36000981 Free article. Clinical Trial.
256 results